Firms

AB Magnitude Ventures Group

abmagnitudeventuresgroupllc.godaddysites.comabmagnitudefund.com

Biotechnology venture investment firm led by computational drug discovery scientist Yibing Shan. It supports scientist founders developing therapeutics and healthcare innovations, including AI-enabled drug discovery, computationally designed oncology medicines and neurorestorative therapies. Public financing sources identify investments in ArrePath, BAKX, Myrobalan, Tasca and Odyssey Therapeutics.

Founded

—

Type

Venture capital

Team

Operations and support

Yibing ShanFounding Managing Director

SHOW MORE

Co-investing

3E Bioventures Capital

• Myrobalan Therapeutics$24M · 2024-01-10

Boehringer Ingelheim Venture Fund

• ArrePath$— · 2025-06-23

Elena Viboch

• Odyssey Therapeutics$101M · 2023-12-05

Innospark Ventures

• ArrePath$— · 2025-06-23

Insight Partners

• ArrePath$— · 2025-06-23

SHOW MORE

Investments

$—2025-06-23	ArrePath	Boehringer Ingelheim Venture Fund, Insight Partners, Innospark Ventures, Nor'easter Ventures, AB Magnitude Ventures Group
$24M2024-01-10	Myrobalan Therapeutics	3E Bioventures Capital, AB Magnitude Ventures Group
$101M2023-12-05	Odyssey Therapeutics	Elena Viboch, AB Magnitude Ventures Group

SHOW MORE